{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T14:02:18Z","timestamp":1793800938690,"version":"4.6.1"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Antiplatelet treatment is recommended to start 24\u2005h after intravenous thrombolysis due to concerns about haemorrhagic transformation. This study aimed to investigate the potential benefit of early antiplatelet after intravenous thrombolysis in minor stroke.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A multicentre, double-blind, randomized trial was conducted in China between 7 August 2022 and 1 August 2024, to evaluate the efficacy and safety of early antiplatelet in acute ischaemic stroke patients presenting with mild neurological deficits, as indicated by a National Institutes of Health Stroke Scale (NIHSS) score of 0\u20135, who received intravenous thrombolysis. Patients were randomly assigned to receive either clopidogrel and aspirin or placebo within 6\u2005h after intravenous thrombolysis. The primary endpoint was an excellent functional outcome at 90 days, indicated by a modified Rankin Scale (mRS) score of 0\u20131. Statistical analysis was based on a modified intention-to-treat population. Symptomatic intracranial haemorrhage, any intracranial haemorrhage, and major systemic bleeding were safety endpoints.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The primary endpoint was not met in this study. Of the randomly assigned 1022 patients, 995 patients were included in the modified intention-to-treat analysis (503 with early antiplatelet treatment and 492 with placebo). The primary endpoint occurred in 89.7% (451\/503) of patients receiving early antiplatelet vs 89.6% (441\/492) of those receiving placebo with no significant difference (odds ratio 1.00, 95% confidence interval .67\u20131.51, P = .99). Similar safety profiles were found between the two groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among Chinese patients with acute minor ischaemic stroke who received intravenous thrombolysis, early antiplatelet treatment with clopidogrel plus aspirin was safe but did not improve already excellent functional outcome (mRS 0\u20131) at 90 days.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehaf702","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T11:23:36Z","timestamp":1756121016000},"page":"746-756","source":"Crossref","is-referenced-by-count":16,"title":["Early antiplatelet treatment for minor stroke following thrombolysis: the EAST trial"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7486-1992","authenticated-orcid":false,"given":"Hui-Sheng","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Neurology, General Hospital of Northern Theater Command , 83 Wenhua Rd, Shenyang 110016 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4925-1500","authenticated-orcid":false,"given":"Yu","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Neurology, General Hospital of Northern Theater Command , 83 Wenhua Rd, Shenyang 110016 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qiu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, General Hospital of Northern Theater Command , 83 Wenhua Rd, Shenyang 110016 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Hong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, General Hospital of Northern Theater Command , 83 Wenhua Rd, Shenyang 110016 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Hao","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Lvshunkou District Hospital of Traditional Chinese Medicine , Dalian ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Donggang Central Hospital , Donggang ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Mei","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tonghua Vascular Disease Hospital , Tonghua ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Wei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Anshan Changda Hospital , Anshan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Neurology, Anshan Changda Hospital , Anshan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Ning","family":"Mi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Ulanqab Central Hospital , Ulanqab ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Linghai Dalinghe Hospital , Linghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, General Hospital of Fushun Mining Bureau of Liaoning Health Industry Group , Fushun ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Jun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Togtoh County Hospital , Togtoh ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Er-Qiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fuqing Hospital Affiliated of Fujian Medical University , Fuqing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fushun Central Hospital , Fushun ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Guang","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Neurology, Benxi Central Hospital , Benxi ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tieling County Central Hospital , Tieling ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Yao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tongliao People\u2019s Hospital , Tongliao ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Guo","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Neurology, Linfen Central Hospital , Linfen ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Jilin University , Changchun ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Mei","family":"Geng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beipiao Central Hospital , Beipiao ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Gansu Province Central Hospital , Lanzhou ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2788-2464","authenticated-orcid":false,"given":"Duo-Lao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine , Liverpool ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh N","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Radiology, Boston Medical Center , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"key":"2026021113020143300_ehaf702-B1","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the Early Management of Acute Ischemic Stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"2026021113020143300_ehaf702-B2","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3760\/cma.j.cn113694-20240410-00221","article-title":"Guidelines for the diagnosis and treatment of acute ischemic stroke in China 2023","volume":"57","author":"Neurology branch of Chinese Medical Association","year":"2024","journal-title":"Chin J Neurol"},{"key":"2026021113020143300_ehaf702-B3","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1161\/STROKEAHA.119.028287","article-title":"The incidence and associated factors of early neurological deterioration after thrombolysis: results from SITS registry","volume":"51","author":"Yu","year":"2020","journal-title":"Stroke"},{"key":"2026021113020143300_ehaf702-B4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1161\/01.STR.0000251800.01964.f6","article-title":"Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study","volume":"38","author":"Saqqur","year":"2007","journal-title":"Stroke"},{"key":"2026021113020143300_ehaf702-B5","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1212\/wnl.59.6.862","article-title":"Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator","volume":"59","author":"Alexandrov","year":"2002","journal-title":"Neurology"},{"key":"2026021113020143300_ehaf702-B6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.5853\/jos.2024.02250","article-title":"Early neurological deterioration and time to start dual antiplatelet therapy in patients with acute mild-to-moderate ischemic stroke: a Pre-specified post hoc analysis of the ATAMIS trial","volume":"26","author":"Cui","year":"2024","journal-title":"J Stroke"},{"key":"2026021113020143300_ehaf702-B7","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1161\/STROKEAHA.108.517656","article-title":"The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial","volume":"39","author":"Pancioli","year":"2008","journal-title":"Stroke"},{"key":"2026021113020143300_ehaf702-B8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1161\/STROKEAHA.114.006743","article-title":"Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis","volume":"46","author":"Adeoye","year":"2015","journal-title":"Stroke"},{"key":"2026021113020143300_ehaf702-B9","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1161\/STROKEAHA.115.010260","article-title":"Combined approach to lysis utilizing eptifibatide and recombinant tissue-type plasminogen activator in acute ischemic stroke-full dose regimen stroke trial","volume":"46","author":"Adeoye","year":"2015","journal-title":"Stroke"},{"key":"2026021113020143300_ehaf702-B10","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1161\/STROKEAHA.116.014413","article-title":"Safety and preliminary efficacy of early tirofiban treatment after alteplase in acute ischemic stroke patients","volume":"47","author":"Li","year":"2016","journal-title":"Stroke"},{"key":"2026021113020143300_ehaf702-B11","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.12.044","article-title":"Efficacy of tirofiban administered at different time points after intravenous thrombolytic therapy with alteplase in patients with acute ischemic stroke","volume":"28","author":"Liu","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2026021113020143300_ehaf702-B12","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0140-6736(12)60949-0","article-title":"Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial","volume":"380","author":"Zinkstok","year":"2012","journal-title":"Lancet"},{"key":"2026021113020143300_ehaf702-B13","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1161\/STROKEAHA.112.665331","article-title":"Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies","volume":"43","author":"Whiteley","year":"2012","journal-title":"Stroke"},{"key":"2026021113020143300_ehaf702-B14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/2396987317746003","article-title":"Minor stroke due to large artery occlusion. When is intravenous thrombolysis not enough? Results from the SITS International Stroke Thrombolysis Register","volume":"3","author":"Mazya","year":"2018","journal-title":"Eur Stroke J"},{"key":"2026021113020143300_ehaf702-B15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jamaneurol.2020.4557","article-title":"Prediction of early neurological deterioration in individuals with minor stroke and large vessel occlusion intended for intravenous thrombolysis alone","volume":"78","author":"Seners","year":"2021","journal-title":"JAMA Neurol"},{"key":"2026021113020143300_ehaf702-B16","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1001\/jama.2023.7827","article-title":"Dual antiplatelet therapy vs alteplase for patients with minor nondisabling acute ischemic stroke: the ARAMIS randomized clinical trial","volume":"329","author":"Chen","year":"2023","journal-title":"JAMA"},{"key":"2026021113020143300_ehaf702-B17","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1001\/jama.2018.8496","article-title":"Effect of alteplase vs aspirin on functional outcome for patients with acute ischemic stroke and minor nondisabling neurologic deficits: the PRISMS randomized clinical trial","volume":"320","author":"Khatri","year":"2018","journal-title":"JAMA"},{"key":"2026021113020143300_ehaf702-B18","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1016\/S0140-6736(24)00921-8","article-title":"Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial","volume":"403","author":"Coutts","year":"2024","journal-title":"Lancet"},{"key":"2026021113020143300_ehaf702-B19","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","article-title":"Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials","volume":"384","author":"Emberson","year":"2014","journal-title":"Lancet"},{"key":"2026021113020143300_ehaf702-B20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack","volume":"369","author":"Wang","year":"2013","journal-title":"N Engl J Med"},{"key":"2026021113020143300_ehaf702-B21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA","volume":"379","author":"Johnston","year":"2018","journal-title":"N Engl J Med"},{"key":"2026021113020143300_ehaf702-B22","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1161\/CIRCULATIONAHA.119.040713","article-title":"Time course for benefit and risk of clopidogrel and aspirin after acute transient ischemic attack and minor ischemic stroke","volume":"140","author":"Johnston","year":"2019","journal-title":"Circulation"},{"key":"2026021113020143300_ehaf702-B23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1474-4422(10)70060-0","article-title":"Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial","volume":"9","author":"Wong","year":"2010","journal-title":"Lancet Neurol"},{"key":"2026021113020143300_ehaf702-B24","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1212\/WNL.0000000000001972","article-title":"Dual antiplatelet therapy in stroke and ICAS: subgroup analysis of CHANCE","volume":"85","author":"Liu","year":"2015","journal-title":"Neurology"},{"key":"2026021113020143300_ehaf702-B25","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1177\/17474930221118900","article-title":"Early antiplatelet for minor stroke following thrombolysis (EAST): rationale and design","volume":"18","author":"Li","year":"2023","journal-title":"Int J Stroke"},{"key":"2026021113020143300_ehaf702-B26","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1161\/STROKEAHA.114.005135","article-title":"Defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the National Institute of Neurological Disorders and Stroke tissue-type plasminogen activator trials","volume":"45","author":"Rao","year":"2014","journal-title":"Stroke"},{"key":"2026021113020143300_ehaf702-B27","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1136\/svn-2020-000640","article-title":"Effectiveness of intravenous r-tPA versus UK for acute ischaemic stroke: a nationwide prospective Chinese registry study","volume":"6","author":"Wang","year":"2021","journal-title":"Stroke Vasc Neurol"},{"key":"2026021113020143300_ehaf702-B28","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1001\/jama.2023.0550","article-title":"Effect of argatroban plus intravenous alteplase vs intravenous alteplase alone on neurologic function in patients with acute ischemic stroke: the ARAIS randomized clinical trial","volume":"329","author":"Chen","year":"2023","journal-title":"JAMA"},{"key":"2026021113020143300_ehaf702-B29","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa2314779","article-title":"Adjunctive intravenous argatroban or eptifibatide for ischemic stroke","volume":"391","author":"Adeoye","year":"2024","journal-title":"N Engl J Med"},{"key":"2026021113020143300_ehaf702-B30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12883-024-04000-8","article-title":"Safety and efficacy of intravenous thrombolysis: a systematic review and meta-analysis of 93,057 minor stroke patients","volume":"25","author":"Moawad","year":"2025","journal-title":"BMC Neurol"},{"key":"2026021113020143300_ehaf702-B31","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.05.007","article-title":"Cognition and quality of life in symptomatic carotid occlusion","volume":"28","author":"Pavol","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2026021113020143300_ehaf702-B32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/jama.2016.8662","article-title":"Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack","volume":"316","author":"Wang","year":"2016","journal-title":"JAMA"},{"key":"2026021113020143300_ehaf702-B33","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1056\/NEJMoa2111749","article-title":"Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA","volume":"385","author":"Wang","year":"2021","journal-title":"N Engl J Med"},{"key":"2026021113020143300_ehaf702-B34","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1177\/23969873231225069","article-title":"Early tirofiban administration after intravenous thrombolysis in acute ischemic stroke (ADVENT): study protocol of a multicenter, randomized, double-blind, placebo-controlled clinical trial","volume":"9","author":"Guo","year":"2024","journal-title":"Eur Stroke J"},{"key":"2026021113020143300_ehaf702-B35","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.122.060666","article-title":"Early versus delayed non-vitamin K antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation (TIMING): a registry-based randomized controlled noninferiority study","volume":"146","author":"Oldgren","year":"2022","journal-title":"Circulation"},{"key":"2026021113020143300_ehaf702-B36","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMoa2303048","article-title":"Early versus later anticoagulation for stroke with atrial fibrillation","volume":"388","author":"Fischer","year":"2023","journal-title":"N Engl J Med"},{"key":"2026021113020143300_ehaf702-B37","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1001\/jamaneurol.2024.0146","article-title":"Clopidogrel plus aspirin vs aspirin alone in patients with acute mild to moderate stroke: the ATAMIS randomized clinical trial","volume":"81","author":"Chen","year":"2024","journal-title":"JAMA Neurol"},{"key":"2026021113020143300_ehaf702-B38","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0140-6736(16)30468-8","article-title":"Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials","volume":"388","author":"Rothwell","year":"2016","journal-title":"Lancet"},{"key":"2026021113020143300_ehaf702-B39","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1177\/17407745251324865","article-title":"Commentary on Wittes et al: aspirin for primary prevention of CV events\u2014rationally robust? Statistically significant? Clinically convincing?","volume":"22","author":"Cleland","year":"2025","journal-title":"Clin Trials"},{"key":"2026021113020143300_ehaf702-B40","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1161\/STROKEAHA.117.018427","article-title":"STARTING-SICH Nomogram to predict symptomatic intracerebral hemorrhage after intravenous thrombolysis for stroke","volume":"49","author":"Cappellari","year":"2018","journal-title":"Stroke"},{"key":"2026021113020143300_ehaf702-B41","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1056\/NEJMoa2309137","article-title":"Dual antiplatelet treatment up to 72 hours after ischemic stroke","volume":"389","author":"Gao","year":"2023","journal-title":"N Engl J Med"},{"key":"2026021113020143300_ehaf702-B42","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/09537104.2021.1894326","article-title":"Intravenous abciximab as a rescue therapy for immediate reocclusion after successful mechanical thrombectomy in acute ischemic stroke patients","volume":"33","author":"Delvoye","year":"2022","journal-title":"Platelets"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/6\/746\/64326544\/ehaf702.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/6\/746\/64326544\/ehaf702.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:02:09Z","timestamp":1770832929000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/47\/6\/746\/8258727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,9,19]]},"published-print":{"date-parts":[[2026,2,11]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehaf702","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2,7]]},"published":{"date-parts":[[2025,9,19]]}}}